OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoquinolinone derivatives as potent CNS multi-receptor D2/5-HT1A/5-HT2A/5-HT6/5-HT7 agents: Synthesis and pharmacological evaluation
Jian Jin, Kun-Xiao Zhang, Fei Dou, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112709-112709
Closed Access | Times Cited: 14

Showing 14 citing articles:

The chronic unpredictable mild stress (CUMS) Paradigm: Bridging the gap in depression research from bench to bedside
Shweta Sharma, Shivani Chawla, Praveen Kumar, et al.
Brain Research (2024) Vol. 1843, pp. 149123-149123
Closed Access | Times Cited: 11

Enhanced photocatalytic activity of Fe@UiO-66 for aerobic oxidation of N-aryl tetrahydroisoquinolines
Kai Zhou, Yuanyuan Zhang, Mingjie Liu, et al.
Catalysis Science & Technology (2024) Vol. 14, Iss. 6, pp. 1605-1612
Open Access | Times Cited: 3

The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice
Xia Ren, Jiaying Xiong, Lingzhi Liang, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2755-2755
Open Access | Times Cited: 9

Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands
Gianfabio Giorgioni, Alessandro Bonifazi, Luca Botticelli, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2640-2706
Closed Access | Times Cited: 1

Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants
Quxiang Li, Qiang Guo, Lili Ren, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 114, pp. 117935-117935
Closed Access | Times Cited: 1

Antidepressant Drug Discovery and Development: Mechanism and Drug Design Based on Small Molecules
Chuansheng Yao, Xiaoying Jiang, Xiang‐Yang Ye, et al.
Advanced Therapeutics (2022) Vol. 5, Iss. 5
Closed Access | Times Cited: 7

Synthesis and biological evaluation of 1-(4-(piperazin-1-yl)phenyl)pyridin-2(1H)-one derivatives as potential SSRIs
Tengfei Xu, Ya‐Ping Xue, Jie-Lian Lu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113644-113644
Closed Access | Times Cited: 9

Synthesis and biological evaluation of a new class of multi-target heterocycle piperazine derivatives as potential antipsychotics
Lanchang Gao, Chao Hao, Ru Ma, et al.
RSC Advances (2021) Vol. 11, Iss. 28, pp. 16931-16941
Open Access | Times Cited: 7

Discovery of a novel class of benzoxazole derivatives as histamine H3 receptor ligands for the treatment of neuropathic pain
Ziying Li, Xinyi Xiao, Yulin Xue, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 106039-106039
Closed Access | Times Cited: 4

The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review
Giulia Bononi, Chiara Lonzi, Tiziano Tuccinardi, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 1930-1930
Open Access

Non-Kolbe Oxidation Driven Electrochemical C(sp2)-H Lactonization towards the Synthesis of Isocoumarins
Chen Liu, Hongpeng Liu, Gaoyuan Zhang, et al.
Organic Chemistry Frontiers (2024) Vol. 11, Iss. 23, pp. 6742-6747
Closed Access

Cobalt-catalyzed C–H functionalization for the synthesis of chiral heterocyclic molecules
Linlin Shi, Dandan Yang, Jun‐Long Niu
Elsevier eBooks (2024), pp. 101-120
Closed Access

Advances in Chemistry of 2-(Piperazin-1-yl) Quinoline (Part IV)
Ghada G. El‐Bana, Moustafa A. Gouda
Mini-Reviews in Organic Chemistry (2023) Vol. 21, Iss. 5, pp. 542-554
Closed Access | Times Cited: 1

Page 1

Scroll to top